Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2009; Volume 195, Supplement 667
XXXV Congress of The Spanish Society for Physiological Sciences
2/17/2009-2/20/2009
Valencia, Spain


SIGNAL INTEGRATION BY P38 MAP KINASES
Abstract number: S34

Dolado1 I, Nebreda1 AR

1Centro Nacional de Investigaciones Oncolgicas (CNIO), Madrid, Spain

p38 MAP kinases are activated by many types of environmental stress, inflammatory cytokines and apoptosis inducers, although sometimes may have other functions unrelated to stress, such as the regulation of cell proliferation, differentiation and motility in particular cell types. We have found that p38a, the p38 MAP kinase family member that is expressed ubiquitiously at higher levels, plays an important role in tumor suppression by inducing apoptosis. In particular, p38a detects the production of reactive oxygen species (ROS) by oncogenes and triggers apoptosis in cells with tumorigenic potential. At later stages of the tumorigenic process, however, the interplay between p38a, ROS and apoptosis is different. Thus, established human cancer cell lines have developed mechanisms to interfere with the apoptotic effect of p38a in response to ROS, which results in the accumulation of high levels of oxidative stress and enhanced tumorigenicity. Interestingly, cancer cells with high ROS levels (due to p38a downregulation) appear to be hyper-sensitised to apoptosis induced by cytotoxic agents. Finally, p38a activity has been recently correlated with the enhanced malignancy of certain types of human tumors, in contrast with the negative role of this signalling pathway in cancer initiation as an oxidative stress sensor. We will discuss results on how p38a contributes to human cancer progression.

To cite this abstract, please use the following information:
Acta Physiologica 2009; Volume 195, Supplement 667 :S34

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE